Monday, March 03, 2025 | 10:59 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Price war rages as pharma firms despatch Covid-19 antiviral pill

Competitive pricing among firms keeps rates at Rs 1,400-2,490 for full treatment

covid pill
Premium

The drug inhibits a replication of the Sars-CoV-2 virus and has been approved in the UK and the US

Sohini Das Mumbai
Oral Covid pill Molnupiravir will hit retail stores this week as companies have started despatching the drug all over the country.

Meanwhile, a price war is on among several companies launching Merck’s antiviral drug.

After Mankind Pharma said it would price its Molnupiravir brand Molulife at Rs 35 per capsule, or Rs 1,400 for the full course of 40 capsules (eight capsules a day for five days), as the most “affordable brand” in the market, Hyderabad-based Dr Reddy’s Laboratories (DRL) on Tuesday launched the drug at the same price.

R C Juneja, chairman of Mankind Pharma, said for some drugs affordability, not profit,

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in